Low alpha‐fetoprotein hepatocellular carcinoma

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 9, 2010-09 ,pp. : 1543-1549

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quantification of glypican 3, β‐catenin and claudin‐1 protein expression in hepatoblastoma and paediatric hepatocellular carcinoma by colour deconvolution

By  

HISTOPATHOLOGY, Vol. 67, Iss. 6, 2015-12 ,pp. : 905-913

John Wiley & Sons Inc

Access to resources Recommend Favorite

High preoperative levels of serum glypican‐3 containing N‐terminal subunit are associated with poor prognosis in patients with hepatocellular carcinoma after partial hepatectomy

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 7, 2015-10 ,pp. : 1643-1651

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inhibition of glypican-3 expression via RNA interference influences the growth and invasive ability of the MHCC97-H human hepatocellular carcinoma cell line

By                  

International Journal of Molecular Medicine, Vol. 28, Iss. 4, 2011-01 ,pp. : 497-503

Spandidos Publications

Access to resources Recommend Favorite

The oncofetal gene glypican 3 is regulated in the postnatal liver by zinc fingers and homeoboxes 2 and in the regenerating liver by alpha‐fetoprotein regulator 2

By  

HEPATOLOGY, Vol. 46, Iss. 5, 2007-11 ,pp. : 1541-1547

John Wiley & Sons Inc

Access to resources Recommend Favorite